Patent details

EN | LT

LT - Į ląsteles patenkantys peptidiniai JNK signalo perdavimo kelio inhibitoriai

EN - CELL-PERMEABLE PEPTIDE INHIBITORS OF THE JNK SIGNAL TRANSDUCTION PATHWAY

Legal status

Patent lapsed (non-payment of fees)

Claims | Licences/Sublicenses

Bibliographic data

Indications of the International Patent Classification (IPC)
(51)	INT.CL.	C07K 14/47	(2006.01)

European patent
(11)	Number of the document	1928903
(13)	Kind of document	T
(96)	European patent application number	06792004.1
	Date of filing the European patent application	2006-09-12
(97)	Date of publication of the European application	2008-06-11
(45)	Date of publication and mention of the grant of the patent	2012-05-30
(46)	Date of publication of the claims translation	2012-08-27

PCT application
(86)	Number	PCT/EP2006/008882
	Date	2006-09-12

PCT application publication
(87)	Number	WO 2007/031280
	Date	2007-03-22

Priority applications
(30)	Number	Date	Country code
	PCT/EP2005/0097	2005-09-12	WO

Inventors
(72)	BONNY, Christophe, CH

Grantee
(73)	Xigen Inflammation Ltd., Arch. Makariou III 195 Neocleous House, 3030 Limassol, CY

Attorney or representative
(74)	Marija LENKUTIENĖ, Patentinių paslaugų centras, UAB, Jono Basanavičiaus g. 11/1, LT-03108 Vilnius, LT

Title
(54)	Į ląsteles patenkantys peptidiniai JNK signalo perdavimo kelio inhibitoriai
	CELL-PERMEABLE PEPTIDE INHIBITORS OF THE JNK SIGNAL TRANSDUCTION PATHWAY

Last renewal fee
	Payment date	Validity (years)	Amount
	2019-02-01	13	433.50 EUR

Legal status
	Patent lapsed (non-payment of fees)
	Invalidation date	2019-09-12